210
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Nomogram for Prediction of Diabetic Retinopathy Among Type 2 Diabetes Population in Xinjiang, China

, , ORCID Icon, , &
Pages 1077-1089 | Published online: 07 Apr 2022

References

  • Zhu S, Triest MV, Tong M, et al. Retinal vascular tortuosity in hospitalized patients with type 2 diabetes and diabetic retinopathy in China. J Biomed Sci Eng. 2016;09:143–154. doi:10.4236/jbise.2016.910B019
  • IDF Congress. 2019, shaping the future of diabetes. Diabetes Res Clin Pract. 2019;158:107954. doi:10.1016/j.diabres.2019.107954
  • Wang JK, Ma QT, Li YQ, et al. Research progress on traditional Chinese medicine syndromes of diabetes mellitus. Biomed Pharmacother. 2019;121:109565. doi:10.1016/j.biopha.2019.109565
  • Sun P, Xu N, Li Y, et al. Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation. Int Immunopharmacol. 2020;85:106686. doi:10.1016/j.intimp.2020.106686
  • Zhao K, Liu J, Dong G, et al. Preliminary research on the effects and mechanisms of umbilical cord-derived mesenchymal stem cells in streptozotocin-induced diabetic retinopathy. Int J Mol Med. 2020;46(5):849–858. doi:10.3892/ijmm.2020.4708
  • Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–186. doi:10.1016/j.preteyeres.2015.08.001
  • Knudsen LL, Lervang HH, Lundbye-Christensen S, et al. The North Jutland County diabetic Retinopathy Study, population characteristics. Br J Ophthalmol. 2006;90(11):1404–1409. doi:10.1136/bjo.2006.093393
  • Esteves JF, Kramer CK, Azevedo MJ, et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Revista Da Associao Medica Brasilra. 2009;55(3):268–273. doi:10.1590/S0104-42302009000300017
  • Romero-Aroca P, Baget-Bernaldiz M, Fernandez-Ballart J, et al. Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes Res Clin Pract. 2011;94(1):126–132. doi:10.1016/j.diabres.2011.07.004
  • Yan ZP, Ma JX. Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(8):1194–1199. doi:10.18240/ijo.2016.08.17
  • Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592–596. doi:10.2337/dc11-0943
  • Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: across-sectional study of 13473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280. doi:10.1136/bmjopen-2017-016280
  • Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vision. 2015;2(1):17. doi:10.1186/s40662-015-0026-2
  • Zhou M, Astell-Burt T, Bi Y, et al. Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes Care. 2015;38(1):72–81. doi:10.2337/dc14-1100
  • Giammaria S, Vianna JR, Ohno Y, Iwase A, Chauhan BC. Nomograms for converting perimetric sensitivity from full threshold and SITA fast to SITA standard in patients with glaucoma and healthy subjects. Transl Vis Sci Technol. 2021;10(9):2. doi:10.1167/tvst.10.9.2
  • Kansara N, Landis Z, Seeger C, et al. Nittany nomogram, A method to predict refractive astigmatism after cataract surgery based on pre-operative biometry. Invest Ophthalmol Vis Sci. 2020;61(7):1678.
  • Seeger C, Kansara N, Sun A, et al. Nittany-AK calculator, A novel femtosecond laser-assisted keratotomy nomogram for the management of corneal astigmatism during cataract surgery. Invest Ophthalmol Vis Sci. 2021;62(8):955.
  • Jiang S, Fang J, Chen L, et al. Novel model predicts diabetic nephropathy in type 2 diabetes. Am J Nephrol. 2019;51(2):1–9. doi:10.1159/000505145
  • Fu R, Yang J, Wang H, et al. A nomogram for determining the disease-specific survival in invasive lobular carcinoma of the breast, A population study. Medicine. 2020;99:e22807. doi:10.1097/MD.0000000000022807
  • Xuejun L, Chunxiu G, Ying L. Characteristics and related factors of type 2 diabetes mellitus with non-alcoholic fatty liver disease in children. Chin J Diabetes Mellit. 2018;10(7):482–486.
  • Chinese Medical Association Diabetes Society. Standards of medical care for type 2 diabetes in China (2010). Chin J Front Med Sci. 2011;3(6):54–109. doi:10.3969/j.issn.1674-7372.2011.06.014
  • Mueller-Using S, Feldt T, Sarfo FS, Eberhardt KA. Factors associated with performing tuberculosis screening of HIV-positive patients in Ghana: LASSO-based predictor selection in a large public health data set. BMC Public Health. 2016;16(1):563. doi:10.1186/s12889-016-3239-y
  • Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J.Stat.Softw. 2010;33(1):1–22. doi:10.1016/j.jspi.2009.07.020
  • Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
  • Silva TB, Oliveira CZ, Faria EF, et al. Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil. Anticancer Res. 2015;35(5):2881–2886. doi:10.1166/jnn.2011.3547
  • Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546. doi:10.1001/jama.1982.03320430047030
  • Tran PMH, Kim E, Tran LKH, et al. T1DMicro, A clinical risk calculator for type 1 diabetes related microvascular complications. Int J Environ Res Public Health. 2021;18:11094. doi:10.3390/ijerph182111094
  • Carvalho GMC, Leite TT, Libório AB. Prediction of 60-day case fatality in critically III patients receiving renal replacement therapy: external validation of a prediction model. Shock. 2017;50(2):156–161. doi:10.1097/SHK.0000000000001054
  • Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. JAMA. 2015;313(4):409–410. doi:10.1001/jama.2015.37
  • Chang Q, Yuanbo WU. Analysis of the related risk factors of 710 type 2 diabetes in-patients with DPN. Chin J Neuroimmunol Neurol. 2015;22(5):342–346.
  • Wang Y, Chen S. The research progress of the pathogenesis and protection of diabetic retinopathy nerve injury. Chin J Ocul Fundus Dis. 2014;30(2):209–211.
  • Wei WW, Yang XF, Gu H, Liu NP. Association of diabetic retinopathy with diabetic peripheral neuropathy in type 2 diabetic patients: theBeijing Desheng Diabetic Eye Disease Study. Chin J Ophthalmol. 2017;53(7):509–513. doi:10.3760/cma.j.issn.0412-4081.2017.07.007
  • Liu YY, Wang MH, Andrew D, et al. Glycemic Exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS. DiabetesCare. 2013;36(12):3979–3984. doi:10.2337/dc12-2392
  • Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-564. doi:10.2337/dc11-1909
  • Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111
  • Calderon GD, Juarez OH, Hernandez GE, et al. Oxidative stress and diabetic retinopathy: development and treatment. Eye. 2017;31(8):1122–1130. doi:10.1038/eye.2017.64
  • Solomon SD, Goldberg MF. ETDRS grading of diabetic retinopathy: still the gold standard? Ophthalmic Res. 2019;62(4):190–195. doi:10.1159/000501372
  • Liang C, Shi R, Zhu J, et al. Prevalence and influencing factors of diabetic retinopathy in patients with type 2 diabetes mellitus in Pudong new area of Shanghai. Chin Gen Pract. 2016;19(4):474–478.
  • Ahmed RA, Khalil SN, Ma AQ. Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, SaudiArabia. J Family Community Med. 2016;23(1):18–24. doi:10.4103/2230-8229.172225
  • Cheung CY, Zheng Y, Hsu W, et al. Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors. Ophthalmology. 2011;118(5):812–818. doi:10.1016/j.ophtha.2010.08.045
  • Sasongko MB, Wang JJ, Donaghue KC, et al. Alterations in retinal microvascular geometry in Young type 1 diabetes. Diabetes Care. 2010;33(6):1331–1336. doi:10.2337/dc10-0055
  • Li X, Wong WL, Cheung CY, et al. Racial differences in retinal vessel geometric characteristics: a Multiethnic Study in Healthy Asians. Invest Ophthalmol Vis Sci. 2013;54:3650–3656. doi:10.1167/iovs.12-11126
  • Soto-Pedre E, Pinies JA, Hernaez-Ortega MC. External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus. J Diabetes Complications. 2015;29(4):508–511. doi:10.1016/j.jdiacomp.2014.12.020
  • Mendoza-Herrera K, Quezada AD, Pedroza-Tobías A, et al. A diabetic retinopathy screening tool for low-income adults in Mexico. Prev Chronic Dis. 2017;14(10):E95. doi:10.5888/pcd14.170157
  • Cichosz SL, Johansen MD, Knudsen ST, et al. A classification model for predicting eye disease in newly diagnosed people with type 2 diabetes. Diabetes Res Clin Pract. 2015;108(2):210–215. doi:10.1016/j.diabres.2015.02.020
  • Dai D, Shen Y, Lu J, et al. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes – a prospective cohort study. J Diabetes Complications. 2021;35:107971. doi:10.1016/j.jdiacomp.2021.107971
  • Li G, Veenstra AA, Talahalli RR, et al. Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes. 2012;61(12):3294–3303. doi:10.2337/db11-1249